Connect Biopharma Holdings Limited (CNTB)
NASDAQ · Manufacturing · Pharmaceutical preparations
CNTB price, last 12 months
Key stats
- Previous close
- $0.6652
- Open
- $0.6330
- Day range
- $0.5910 – $0.6500
- 52-week range
- $0.5500 – $3.82
- Volume
- 486.5K
- Avg volume (20 days)
- 580.6K
- Market cap
- $42.6M
Performance
Technicals and fundamentals
About Connect Biopharma Holdings Limited
Connect Biopharma Holdings Ltd is a clinical-stage biopharmaceutical company dedicated to transforming care for asthma and chronic obstructive pulmonary disease (COPD). The company is advancing rademikibart, a next-generation antibody designed to target interleukin-4-receptor alpha. It is currently conducting clinical studies of rademikibart for the treatment of acute exacerbations of asthma and COPD. The company operates in one operating segment: treatment of respiratory diseases.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $42.6M